EGF Theramed Health Corp. (EVAHF) Research
Established in 2011 and based in Vancouver, Canada, EGF Theramed Health Corp. specializes in providing pharmaceutical-grade psychedelic compounds. The company's focus is on developing these substances for the therapeutic management of a variety of mental health challenges, notably anxiety, post-traumatic stress disorder (PTSD), and both general and treatment-resistant forms of depression.
Market snapshot
- Symbol
- EVAHF
- Price
- $0.05
- Day change
- +42.90%
- Market cap
- $891.9K
- P/E ratio
- -0.28x
- 52-week range
- 0.026-0.17454
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
Peer companies
Open EGF Theramed Health Corp. (EVAHF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.